following is a collection of featured adult cardiac
articles in press from the Journal of Thoracic and Cardiovascular
Surgery (JTCVS). To read the latest issue, or
browse the feature video library and other journal
highlights, please visit www.jtcvs.org.
for monthly AATS Journal Alerts here. (Please note you will be asked to login
or create an account for AATS Online.)
previous AATS Journal Alerts here.
add email@example.com to your Safe Sender list.
versus clamped ascending aorta replacement for aortopathy
during initial bicuspid aortic valve replacement
Greason, MD, Juan A. Crestanello, MD, Katherine S.
King, MS, Gabor Bagameri, MD, Sertac M. Cicek, MD, John
M. Stulak, MD, Richard C. Daly, MD, Joseph A. Dearani,
MD, Hartzell V. Schaff, MD
We identify no advantage to hemiarch
replacement in comparison to ascending aorta
replacement with respect to follow-up repeat arch
operation or survival in the absence of aortic arch
Aortic replacement for bicuspid aortic valve
disease—How much is too much (or too little)?
Peter J. Altshuler, MD, Pavan Atluri,
for ascending aortic replacement for bicuspid
aortic valve do not include extent of resection.
With stratification of valvular phenotypes,
tailored therapy may dictate treatment.
Open hemi-arch replacement in bicuspid aortic valve
aortopathy without arch dilatation? If it's not broken,
no need to fix it!
Francois Dagenais, MD
extent of distal aortic resection in patients with
BAV aortopathy is debated. The present study
supports performing a clamped ascending aorta
replacement in the presence of a nondilated arch.
open repairs of chronic distal aortic dissection
anatomically amenable to endovascular repairs
MD, PhD, Harleen K. Sandhu, MD, MPH, Rana O. Afifi, MD,
Charles C. Miller III, PhD, Amberly Ray, BS, Madiha
Hassan, MD, Hazim J. Safi, MD, FACS, Anthony L.
Estrera, MD, FACS
Open surgery provides satisfactory
outcomes, with excellent durability in chronic distal
dissection. It should be considered a mainstay of
treatment, especially in patients without renal or lung
disease and redo.
Stents or surgery for chronic type-B dissection
Aamir Shah, MD, Joanna Chikwe, MD
type-B dissection should be treated by experienced
multidisciplinary teams providing individualized
patient care with deep expertise in both
endovascular and surgical therapeutic modalities.
Like most shortcuts, it could be an ill-chosen route
Michele Di Mauro, MD, PhD, MSc,
Alessandro Parolari, MD, Antonio M. Calafiore, MD
in very expert hands, selecting the right patients
for surgery is still the high road to take rather
than pursuing less invasiveness at all costs.
repair of chronic type B aortic dissection.
survival after xenograft versus homograft aortic root
replacement: Results from a prospective randomized trial
Melina, MD, PhD, Fabio De Robertis, MD, Jullien A.
Gaer, MS, FRCS(C-th), Emiliano Angeloni, MD, PhD,
Ismail El-Hamamsy, MD, PhD, FRCSC, Toufan Bahrami, MD,
John R. Pepper, OBE, MA, MChir, FRCS, Johanna J.M.
Takkenberg, MD, PhD, Magdi H. Yacoub, OM, FRS
Long-term survival of patients
undergoing surgery for aortic valve disease with
Freestyle (Medtronic Inc, Minneapolis, Minn) or
homograft full root replacement is comparable to that
of the age- and sex-matched UK general population.
experience allows robotic mitral valve repair in the
presence of extensive mitral annular calcification
Loulmet, MD, Neel K. Ranganath, MD, Siyamek
Neragi-Miandoab, MD, Michael S. Koeckert, MD, Aubrey C.
Galloway, MD, Eugene A. Grossi, MD
Advanced robotic experience and a
dedicated team approach allow for a high rate of
successful MV repair in the setting of extensive
annular calcification and a pliable posterior leaflet.
Robotic approach to mitral annular calcification—Are we
doing more with less, or is less still more?
Vinay Badhwar, MD
mitral annular calcification robotically requires
significant open surgical experience, with
alternative strategies to ensure patient safety and
a durable outcome.
Handling mitral annulus calcification from behind the
robotic console: The Pugachev's Cobra in cardiac
Gianluca Torregrossa, MD, Umberto Benedetto,
MD, Husam H. Balkhy, MD
mitral valve repair is enhanced using a robotic
approach with a dedicated, experienced 2-surgeon
team even in the presence of complex pathology and
Pushing the boundaries? Robot-assisted excision of
mitral annular calcification
Anelechi C. Anyanwu, MD, Aarti Patil,
MD, David H. Adams, MD
excision of mitral annular calcification can be
done by highly skilled surgical teams but is
associated with increased morbidity. The everyday
surgeon should consider simpler alternatives.
Lessons from 1000 robotic mitral repairs
Joanna Chikwe, MD, FRCS, Alfredo
Trento, MD, Wen Cheng, MD, Dominic Emerson, MD, Danny
mitral repair is reproducible, safe, and effective,
but requires great care when navigating the
multidetector computed tomography assessments after
venous graft treatment solution in coronary artery bypass
Perrault, MD, PhD, Michel Carrier, MD, Pierre Voisine,
Peter Skov Olsen, MD, Nicolas Noiseux,
MD, Hugues Jeanmart, MD, Filippo Cardemartiri, MD, PhD,
Dave Veerasingam, MD, Craig Brown, MD, Marie-Claude
Guertin, PhD, Vilas Satishchandran, MS, Tracy Goeken,
MD, Maximilian Y. Emmert, MD, PhD
SVGs treated with DuraGraft (Somahlution
Inc, Jupiter, Fla) demonstrated favorable results
regarding wall thickness and various other SVG
characteristics versus SVGs treated with saline in
patients undergoing CABG.
How does the vein look? Intraoperative storage strategy
and vein graft disease prevention
Malak Elbatarny, MD, Derrick Y. Tam,
MD, Stephen E. Fremes, MD, MSc, FRCSC
vein graft storage solution impacts 12-month vessel
Dressing for success
Randall Wolf, MD
hope for venous conduits. Lessons learned in
treating vein grafts for coronary artery bypass,
from the disappointing results of PREVENT IV to the
promising results in this issue of the Journal.
mechanical circulatory support device use in the United
States by geographic region and minority status
Bourque, BS, Qixing Liang, MS, Francis D. Pagani, MD,
PhD, Min Zhang, PhD, Keith D. Aaronson, MD, MS, Robert
L. Kormos, MD, Donald S. Likosky, PhD, the Michigan
Congestive Heart Failure Investigators
Geographical differences exist in rates
of durable MCSD implantation among whites and
minorities among UNOS regions in the United States.
Mechanical circulatory support variation in the United
Joseph C. Cleveland Jr., MD
utilization of mechanical circulatory support
varies by geography and race in the United States.
The reasons for this variation are unknown.
Disparities in use of durable mechanical circulatory
support device: Does ethnicity tilt the balance?
Ademola Adeseye, MD, Ravi K. Ghanta,
geographic and racial disparities remain in
virtually all fields of medicine and surgery, MCSD
use has increased in the United States in both
minority and white patients.
To transplant or to support with a ventricular assist
device? Trying to uncover why differences in rates
Vakhtang Tchantchaleishvili, MD, John
W.C. Entwistle, MD, PhD
usage is unevenly distributed by race. The cause of
this disparity is unknown. Changes in UNOS heart
allocation policy may alter MCSD usage, and
follow-up will show if disparities are exacerbated.